Bioxyne Limited

Bioxyne Limited, based in Sydney, Australia, was created through the merger of Hunter Immunology and Probiomics Limited. Bioxyne’s biopharmaceutical business is entering an exciting new phase of its global commercial development. Bioxyne Limited (ASX:BXN) is an Australian life sciences, health and medical technologies company creating value for consumers and investors by developing, marketing and selling consumer health products globally.